1261859-44-2 Usage
Uses
Used in Organic Synthesis:
2-(3-bromo-4-cyanophenyl)acetic acid is used as a building block in organic synthesis for the creation of a variety of molecules. Its functional groups allow for versatile chemical reactions, making it a key component in the synthesis of complex organic compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-(3-bromo-4-cyanophenyl)acetic acid is used as a precursor in the development of new drugs. Its potential biological activities, such as anti-inflammatory and analgesic properties, make it a promising candidate for the treatment of various conditions.
Used in Drug Development:
2-(3-bromo-4-cyanophenyl)acetic acid is employed in drug development as a starting material for the synthesis of pharmaceutical compounds. Its unique structure and properties contribute to the discovery of novel therapeutic agents with improved efficacy and safety profiles.
Used in Medicinal Chemistry Research:
In medicinal chemistry, 2-(3-bromo-4-cyanophenyl)acetic acid is utilized for the study of its structure-activity relationships and the exploration of its potential as a therapeutic agent. This research aids in understanding the compound's interactions with biological targets and its role in the treatment of diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 1261859-44-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,1,8,5 and 9 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1261859-44:
(9*1)+(8*2)+(7*6)+(6*1)+(5*8)+(4*5)+(3*9)+(2*4)+(1*4)=172
172 % 10 = 2
So 1261859-44-2 is a valid CAS Registry Number.
1261859-44-2Relevant academic research and scientific papers
INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
-
Paragraph 0183; 0185; 0188; 0189, (2016/09/26)
no abstract published
INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
-
Paragraph 0165, (2016/01/29)
no abstract published
INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL
-
Page/Page column 51; 52, (2013/03/28)
This invention relates to compounds having structural Formula I: and pharmaceutically acceptable salts thereof which are inhibitors of the Renal Outer Medullary Potassium (ROMK) channel (Kirl.1). The compounds of Formula I are useful as diuretics and natriuretics and therefore are useful for the therapy and prophylaxis of disorders resulting from excessive salt and water retention, including cardiovascular diseases such as hypertension and chronic and acute heart failure
